Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Novo Nordisk Says New Pooled Analysis Published In The Lancet Demonstrated Reduced Risk Of Combined CV Death Or Worsening Heart Failure With Semaglutide - Analysis Conducted Among 3,743 Patients With History Of Heart Failure

Author: Nabaparna Bhattacharya | August 30, 2024 07:41am

Posted In: NVO